UBS Group AG - EDGE THERAPEUTICS INC ownership

EDGE THERAPEUTICS INC's ticker is EDGE and the CUSIP is 279870109. A total of 57 filers reported holding EDGE THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
UBS Group AG ownership history of EDGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2018$25,000
-44.4%
30,897
-29.1%
0.00%
Q2 2018$45,000
+87.5%
43,606
+118.0%
0.00%
Q1 2018$24,000
+200.0%
20,000
+2117.3%
0.00%
Q4 2017$8,000
+14.3%
902
+35.6%
0.00%
Q3 2017$7,000
+75.0%
665
+43.6%
0.00%
Q1 2017$4,000
-92.3%
463
-89.0%
0.00%
Q4 2016$52,000
+188.9%
4,219
+146.7%
0.00%
Q3 2016$18,0000.0%1,710
-5.5%
0.00%
Q2 2016$18,000
-14.3%
1,810
+5.7%
0.00%
Q4 2015$21,0001,7130.00%
Other shareholders
EDGE THERAPEUTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 2,344,868$24,058,00016.90%
VHCP Management II, LLC 1,933,582$19,839,0007.92%
ACUTA CAPITAL PARTNERS, LLC 1,504,612$15,437,0004.32%
Opaleye Management Inc. 130,000$1,334,0000.56%
SPHERA FUNDS MANAGEMENT LTD. 150,000$1,539,0000.26%
DAFNA Capital Management LLC 19,400$199,0000.14%
REGENTATLANTIC CAPITAL LLC 134,900$1,384,0000.13%
MARK SHEPTOFF FINANCIAL PLANNING, LLC 14,400$148,0000.10%
TFS CAPITAL LLC 20,080$206,0000.08%
EAGLE ASSET MANAGEMENT INC 901,359$9,247,0000.06%
View complete list of EDGE THERAPEUTICS INC shareholders